Related Experiment Videos
Infectious disease 2000: drug resistance and new drugs
1DuPont Pharmaceuticals Research Labs, Wilmington, Delaware, USA
Insights
The 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) highlighted microbial resistance and new antimicrobial agents. Key developments in clinical and preclinical research were presented.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- The 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) convened in Toronto, Canada, from September 17-20, 2000.
- The conference attracted a large international audience from both academic and industrial sectors.
- Over 2300 oral and poster presentations were delivered, covering a broad spectrum of infectious disease-related topics.
Purpose of the Study:
- To summarize key findings and emerging trends presented at the 40th ICAAC.
- To focus on advancements in the understanding of microbial resistance mechanisms.
- To highlight novel antimicrobial agents in various stages of development.
Main Methods:
- The summary is based on selected highlights from over 2300 presentations at the conference.
- Focus was placed on topics related to microbial pathogenesis, infection control, vaccines, antibiotic resistance, and new antimicrobial agents.
- Information was gathered from oral and poster presentations covering both clinical and preclinical research.
Main Results:
- Significant progress was discussed in understanding antibiotic resistance.
- Numerous new antimicrobial agents were presented, indicating a robust pipeline in development.
- Advances in microbial pathogenesis and infection control strategies were also featured.
Conclusions:
- The 40th ICAAC showcased substantial progress in combating microbial threats.
- The conference underscored the critical need for continued research into novel antimicrobial agents and resistance mechanisms.
- Future directions in infectious disease management and treatment were outlined.
Abstract:
40th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) was held in Toronto on 17-20 September 2000. It attracted thousands of delegates from industry and academia and covered, in over 2300 oral and poster presentations, topics ranging from microbial pathogenesis to infection control, vaccines, antibiotic resistance and new antimicrobial agents. Summarized here are highlights on microbial resistance and agents in clinical and preclinical development. Copyright 2000 Harcourt Publishers Ltd.